The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

cepA  -  beta-lactamase

Bacteroides fragilis NCTC 9343

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of cepA

  • Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A beta-lactamases [1].
  • Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile [2].
 

High impact information on cepA

  • A variety of 1beta-methylcarbapenem derivatives were screened to identify inhibitors of IMP-1 metallo-beta-lactamase, a class B beta-lactamase, in an automated microassay system using nitrocefin as a substrate [3].
  • Against E. cloacae producing high levels of class C beta-lactamase, the MIC of ceftazidime decreased from 64 to 4 microg/ml in the presence of 4 microg of J-110,441 per ml [3].
  • Combining imipenem or ceftazidime with J-110,441 had a synergistic effect on the antimicrobial activity against beta-lactamase-producing bacteria [3].
  • The 903-bp cepA open reading frame encoded a 300-amino-acid precursor protein (predicted molecular mass, 34,070 Da) [1].
  • Nucleotide sequence comparisons revealed that there were few differences between the cepA coding sequences of the low- and high-activity strains [4].
 

Chemical compound and disease context of cepA

  • Carbapenems, beta-lactamase inhibitor combinations and metronidazole retained good activity, while all Bacteroides fragilis group species produced beta-lactamase and were penicillin resistant and 43% were either intermediately susceptible or resistant to clindamycin [5].
 

Biological context of cepA

  • However, the insertion did not alter the cepA transcription start site, which occurred 27 bp upstream of the ATG translation start codon in both expression classes [4].
  • Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes [6].
  • The cepA gene was observed in total DNA and in the 5.5-kb plasmid [7].
 

Associations of cepA with chemical compounds

  • Each B. fragilis division was associated with the presence of a different antibiotic resistance gene: cepA encoding a serine-beta-lactamase (division I) and cfiA encoding a metallo-beta-lactamase (division II) [8].
  • In this study, resistance to cefoxitin, plasmid profile and beta-lactamase production in species of the B. fragilis group isolated from intestinal tracts of calves were evaluated [7].
 

Other interactions of cepA

 

Analytical, diagnostic and therapeutic context of cepA

  • All strains were also investigated for the presence of cepA, cfiA, cfxA, ermF and tetQ genes by PCR methodology and 92.9, 4.9, 24.2, 2 and 64.6% of the strains were respectively found positive [9].

References

  1. Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A beta-lactamases. Rogers, M.B., Parker, A.C., Smith, C.J. Antimicrob. Agents Chemother. (1993) [Pubmed]
  2. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile. Rossolini, G.M., Franceschini, N., Riccio, M.L., Mercuri, P.S., Perilli, M., Galleni, M., Frere, J.M., Amicosante, G. Biochem. J. (1998) [Pubmed]
  3. Carbapenem derivatives as potential inhibitors of various beta-lactamases, including class B metallo-beta-lactamases. Nagano, R., Adachi, Y., Imamura, H., Yamada, K., Hashizume, T., Morishima, H. Antimicrob. Agents Chemother. (1999) [Pubmed]
  4. Insertional activation of cepA leads to high-level beta-lactamase expression in Bacteroides fragilis clinical isolates. Rogers, M.B., Bennett, T.K., Payne, C.M., Smith, C.J. J. Bacteriol. (1994) [Pubmed]
  5. In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections. Goldstein, E.J., Citron, D.M., Vaidya, S.A., Warren, Y.A., Tyrrell, K.L., Vreni Merriam, C., Fernandez, H. Anaerobe (2006) [Pubmed]
  6. Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes. Gutacker, M., Valsangiacomo, C., Piffaretti, J.C. Microbiology (Reading, Engl.) (2000) [Pubmed]
  7. Plasmid-Related Resistance to Cefoxitin in Species of the Bacteroides fragilis Group Isolated from Intestinal Tracts of Calves. Dos Santos Almeida, F., Avila-Campos, M.J. Curr. Microbiol. (2006) [Pubmed]
  8. RecA and glnA sequences separate the bacteroides fragilis population into two genetic divisions associated with the antibiotic resistance genotypes cepA and cfiA. Gutacker, M., Valsangiacomo, C., Bernasconi, M.V., Piffaretti, J.C. J. Med. Microbiol. (2002) [Pubmed]
  9. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility. Paula, G.R., Falcão, L.S., Antunes, E.N., Avelar, K.E., Reis, F.N., Maluhy, M.A., Ferreira, M.C., Domingues, R.M. Int. J. Antimicrob. Agents (2004) [Pubmed]
 
WikiGenes - Universities